AMY LARSON: Open Payments
NPI 1417285784 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 45 payments from 12 companies in 2025. Trend: 2023 $1,349 · 2024 $1,581 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $249 |
| Collegium Pharmaceutical, Inc. | 9 | $172 |
| ABBVIE INC. | 7 | $139 |
| PFIZER INC. | 4 | $105 |
| Amgen Inc. | 2 | $38 |
| Medtronic, Inc. | 2 | $36 |
| Globus Medical, Inc. | 1 | $35 |
| Electronic Waveform Lab, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| SCILEX PHARMACEUTICALS INC. | 1 | $21 |
Products named: RELISTOR, XTAMPZA, NURTEC ODT, QULIPTA, UBRELVY, Belbuca, KRYSTEXXA, Senza.
Industry payments across MD — which companies pay providers there.
